[HTML][HTML] Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal …

K Hisamoto, M Ohmichi, Y Kanda, K Adachi… - Journal of Biological …, 2001 - ASBMB
Raloxifene is a tissue-selective estrogen receptor modulator. The effect of estrogen on
cardiovascular disease is mainly dependent on direct actions on the vascular wall involving …

[PDF][PDF] Induction of Endothelial Nitric-oxide Synthase Phosphorylation by the Raloxifene Analog LY117018 Is Differentially Mediated by Akt and Extracellular Signal …

K Hisamoto, M Ohmichi, Y Kanda, K Adachi, Y Nishio… - 2001 - academia.edu
Raloxifene is a tissue-selective estrogen receptor modulator. The effect of estrogen on
cardiovascular disease is mainly dependent on direct actions on the vascular wall involving …

Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal-regulated …

K Hisamoto, M Ohmichi, Y Kanda… - The Journal of …, 2001 - pubmed.ncbi.nlm.nih.gov
Raloxifene is a tissue-selective estrogen receptor modulator. The effect of estrogen on
cardiovascular disease is mainly dependent on direct actions on the vascular wall involving …

[HTML][HTML] Induction of Endothelial Nitric-oxide Synthase Phosphorylation by the Raloxifene Analog LY117018 Is Differentially Mediated by Akt and Extracellular Signal …

K Hisamoto, M Ohmichi, Y Kanda, K Adachi… - Journal of Biological …, 2001 - Elsevier
Raloxifene is a tissue-selective estrogen receptor modulator. The effect of estrogen on
cardiovascular disease is mainly dependent on direct actions on the vascular wall involving …

Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal-regulated …

K Hisamoto, M Ohmichi, Y Kanda, K Adachi… - Journal of Biological …, 2001 - hero.epa.gov
Raloxifene is a tissue-selective estrogen receptor modulator. The effect of estrogen on
cardiovascular disease is mainly dependent on direct actions on the vascular wall involving …

Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal-regulated …

K Hisamoto, M Ohmichi, Y Kanda, K Adachi… - The Journal of …, 2001 - europepmc.org
Raloxifene is a tissue-selective estrogen receptor modulator. The effect of estrogen on
cardiovascular disease is mainly dependent on direct actions on the vascular wall involving …

[PDF][PDF] Induction of Endothelial Nitric-oxide Synthase Phosphorylation by the Raloxifene Analog LY117018 Is Differentially Mediated by Akt and Extracellular Signal …

K Hisamoto, M Ohmichi, Y Kanda, K Adachi, Y Nishio… - 2001 - researchgate.net
Raloxifene is a tissue-selective estrogen receptor modulator. The effect of estrogen on
cardiovascular disease is mainly dependent on direct actions on the vascular wall involving …

[引用][C] Induction of Endothelial Nitric-oxide Synthase Phosphorylation by the Raloxifene Analog LY117018 Is Differentially Mediated by Akt and Extracellular Signal …

K Hisamoto, M Ohmichi, Y Kanda, K Adachi… - Journal of Biological …, 2001 - cir.nii.ac.jp
Induction of Endothelial Nitric-oxide Synthase Phosphorylation by the Raloxifene Analog
LY117018 Is Differentially Mediated by Akt and Extracellular Signal-regulated Protein Kinase …

[引用][C] Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal …

K HISAMOTO - J Biol Chem, 2001 - cir.nii.ac.jp
Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog
LY117018 is differentially mediated by Akt and extracellular signal-regulated protein kinase in …